Lorenzo F. Fanchi

Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers

Myriam Chalabi, Lorenzo F. Fanchi, Krijn K. Dijkstra et al. · Nature Medicine · 2020 · 1.4K citations · Full text

Medicine, Oncology, Pathology +14

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids

Krijn K. Dijkstra, Chiara M. Cattaneo, Fleur Weeber et al. · Cell · 2018 · 1.1K citations · Full text

Life Sciences, Immunology, Oncology +15

Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma

Christian U. Blank, Elisa A. Rozeman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 855 citations

Medicine, Immunology, Oncology +14

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

Wouter Scheper, Sander Kelderman, Lorenzo F. Fanchi et al. · Nature Medicine · 2018 · 579 citations · Full text

Medicine, Immunology, Oncology +16

Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction

Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang et al. · Cell · 2020 · 536 citations · Full text

Life Sciences, Immunology, Oncology +16